Brief: SeQuent Scientific's unit Alivira completes acquisition of 70 pct stake in Brazil's Interchange
Aug 1 (Reuters) - SeQuent Scientific Ltd SEQU.NS : * Unit Alivira completes the acquisition of 70 percent stake in Interchange, Brazil * Further company coverage SEQU.NS ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Viyash Scientific
See all newsBrief: Viyash Scientific Says Bioforlife Italia Acquisition Expected To Complete Within Two Months From Sept 8
Brief: Viyash Scientific Ltd June-Quarter Consol Net Profit 658.7 Million Rupees
Brief: Viyash Scientific's Subsidiary To Buy 100% Of Bioforlife Italia
Brief: Viyash Scientific March-Quarter Consol Net Profit 521.1 Million Rupees
Brief: Viyash Scientific Partners With Boehringer Ingelheim In India